Abstract
The aim of the present work was to better understand the drug-release mechanism from sustained release matrices prepared with two new polyurethanes, using a novel in silico formulation tool based on 3-dimensional cellular automata. For this purpose, two polymers and theophylline as model drug were used to prepare binary matrix tablets. Each formulation was simulated in silico, and its release behavior was compared to the experimental drug release profiles. Furthermore, the polymer distributions in the tablets were imaged by scanning electron microscopy (SEM) and the changes produced by the tortuosity were quantified and verified using experimental data. The obtained results showed that the polymers exhibited a surprisingly high ability for controlling drug release at low excipient concentrations (only 10% w/w of excipient controlled the release of drug during almost 8 h). The mesoscopic in silico model helped to reveal how the novel biopolymers were controlling drug release. The mechanism was found to be a special geometrical arrangement of the excipient particles, creating an almost continuous barrier surrounding the drug in a very effective way, comparable to lipid or waxy excipients but with the advantages of a much higher compactability, stability, and absence of excipient polymorphism.
Similar content being viewed by others
References
Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials. 2000;21(23):2335–46.
Jagur-Grodzinski J. Biomedical application of functional polymers. React Funct Polym. 1999;39(2):99–138.
Jagur-Grodzinski J. Polymers for tissue engineering, medical devices, and regenerative medicine. Concise general review of recent studies. Polym Adv Technol. 2006;17:395–418.
Langer R, Peppas NA. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J. 2003;49(12):2990–3006.
Lyman DJ. Polyurethanes. I. The solution polymerization of diisocyanates with ethylene glycol. J Polym Sci. 1960;45(145):49–59.
Blackwell J, Gardner KH. Structure of the hard segments in polyurethane elastomers. Polymer (Guildf). 1979;20(1):13–7.
Blackwell J, Lee CD. Hard-segment polymorphism in MDI/diol-based polyurethane elastomers. J Polym Sci Part A-2 Polym Phys. 1984;22(4):759–72.
Weisenberg BA, Mooradian DL. Hemocompatibility of materials used in microelectromechanical systems: platelet adhesion and morphology in vitro. J Biomed Mater Res. 2002;60(2):283–91.
Ferris C, Violante De Paz M, Zamora F, Galbis JA. Dithiothreitol-based polyurethanes. Synthesis and degradation studies. Polym Degrad Stab. 2010;95(9):1480–7.
Wiggins MJ, Wilkoff B, Anderson JM, Hiltner A. Biodegradation of polyether polyurethane inner insulation in bipolar pacemaker leads. J Biomed Mater Res. 2001;58(3):302–7.
Santerre JP, Woodhouse K, Laroche G, Labow RS. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials. Biomaterials. 2005;26(35):7457–70.
Christenson EM, Anderson JM, Hiltner A. Biodegradation mechanisms of polyurethane elastomers. Corros Eng Sci Technol. 2007;42(4):312–23.
Aguilar-De-Leyva, Ángela. Campiñez, María Dolores. Casas, Marta. Caraballo I. Critical points and phase transitions in polymeric matrices for controlled drug release. In: Handbook of polymers for pharmaceutical technologies, Volume 1, Structure and Chemistry. Wiley; 2015. p. 101–42.
Chen X, Liu W, Zhao Y, Jiang L, Xu H, Yang X. Preparation and characterization of PEG-modified polyurethane pressure-sensitive adhesives for transdermal drug delivery. Drug Dev Ind Pharm. 2009;35(6):704–11.
Cherng JY, Hou TY, Shih MF, Talsma H, Hennink WE. Polyurethane-based drug delivery systems. Int J Pharm. 2013;450(1-2):145–62.
Gansen P, Dittgen M. Polyurethanes as self adhesive matrix for the transdermal drug delivery of testosterone. Drug Dev Ind Pharm. 2012;38(5):597–602.
Campiñez MD, Ferris C, de Paz MV, Aguilar-de-Leyva A, Galbis J, Caraballo I. A new biodegradable polythiourethane as controlled release matrix polymer. Int J Pharm. 2015;480:63–72.
Campiñez MD, Aguilar-de-Leyva Á, Ferris C, de Paz MV, Galbis JA, Caraballo I. Study of the properties of the new biodegradable polyurethane PU (TEG-HMDI) as matrix forming excipient for controlled drug delivery. Drug Dev Ind Pharm. 2013;39:1758–64.
Caraballo I. Factors affecting drug release from hydroxypropyl methyl cellulose matrix systems in the light of classical and percolation theories. Expert Opin Drug Deliv. 2010;7(11):1291–301.
Leuenberger H, Lanz M. Pharmaceutical powder technology—from art to science: the challenge of the FDA’s process analytical technology initiative. Adv Powder Technol. 2005;16(1):3–25.
Aguilar-De-Leyva Á, Gonçalves-Araujo T, Daza V, Caraballo I. A new deferiprone controlled release system obtained by ultrasound-assisted compression. Pharm Dev Technol. 2014;19(6):728–34.
Gonçalves-Araújo Rajabi-Siahboomi A, Caraballo I. Application of Percolation Theory in the Study of an Extended Release Verapamil Hydrochloride Formulation. Int J Pharm. 2010;361(1–2):112–7.
Miranda A, Millán M, Caraballo I. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets. J Pharm Sci. 2007;96(10):2746–56.
Ramírez N, Melgoza LM, Kuentz M, Sandoval H, Caraballo I. Comparison of different mathematical models for the tensile strength-relative density profiles of binary tablets. Eur J Pharm Sci. 2004;22(1):19–23.
Costa E, Arancibia A, Aïache JM. Sistemas matriciales. Acta Farm Bonaer. 2004;23(2):259–65.
Casas M, Aguilar-de-Leyva Á, Caraballo I. Towards a rational basis for selection of excipients: excipient efficiency for controlled release. Int J Pharm Elsevier BV. 2015;494(1):288–95.
Puchkov M, Tschirky D, Leuenberger H. 3-D cellular automata in computer-aided design of pharmaceutical formulations: mathematical concept and F-CAD software. In: Formulation Tools for Pharmaceutical Development. Elsevier; 2013. p. 155–201.
Eberle VA, Schoelkopf J, Gane PAC, Alles R, Huwyler J, Puchkov M. Floating gastroretentive drug delivery systems: comparison of experimental and simulated dissolution profiles and floatation behavior. Eur J Pharm Sci Elsevier BV. 2014;58(1):34–43.
Eberle VA, Häring A, Schoelkopf J, Gane PAC, Huwyler J, Puchkov M. In silico and in vitro methods to optimize the performance of experimental gastroretentive floating mini-tablets. Drug Dev Ind Pharm. Taylor & Francis; 2015;1–10.
Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc [Internet]. 1897;19(12):930–4.
van Brakel J, Heertjes PM. Analysis of diffusion in macroporous media in terms of a porosity, a tortuosity and a constrictivity factor. Int J Heat Mass Transf. 1974;17(9):1093–103.
Acknowledgments
The authors would like to express their gratitude to the Spanish Ministry of Economy and Competitiveness and FEDER Funds (European Union) for the support of the project MAT2012-38044-C03-01 and MAT2012- 38044-C03-02 and the Regional Government of Andalusia for the support of the project P12-FQM-1553.
Financial support for this work was provided by School of Life Sciences at the University of Applied Sciences and Arts (Muttenz, Switzerland) and the University of Seville (Seville, Spain).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to disclose.
Rights and permissions
About this article
Cite this article
Campiñez, M.D., Caraballo, I., Puchkov, M. et al. Novel Polyurethane Matrix Systems Reveal a Particular Sustained Release Behavior Studied by Imaging and Computational Modeling. AAPS PharmSciTech 18, 1544–1553 (2017). https://doi.org/10.1208/s12249-016-0613-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-016-0613-0